SEQUENTIAL CISPLATIN (DDP) AND 5-FLUOROURACIL (FU) IN ADVANCED SQUAMOUS-CELL HEAD AND NECK-CANCER (H-AND-N CA)

被引：0
|
作者：
SRIDHAR, KS
HIRSCH, R
FOUNTZILAS, G
GOODWIN, WJ
ROBINSON, D
BRODER, LE
机构：
[1] COMPREHENS CANC CTR STATE FLORIDA,MIAMI,FL 33152
[2] UNIV MIAMI,SCH MED,MIAMI,FL 33152
[3] VET ADM HOSP,MIAMI,FL 33101
来源：
PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH | 1984年 / 25卷 / MAR期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：180 / 180
页数：1
相关论文
共 50 条
  • [1] CONTINUOUS INFUSION 5-FLUOROURACIL (FU) WITH CONCURRENT RADIATION (X) FOR STAGE-IV HEAD AND NECK-CANCER (H-AND-N CA)
    SEAGREN, SL
    BYFIELD, JE
    TANG, S
    SHARP, T
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1981, 22 (MAR): : 533 - 533
  • [2] A PROSPECTIVE EVALUATION OF 5-FLUOROURACIL PLUS CISPLATIN IN ADVANCED SQUAMOUS-CELL CANCER OF THE HEAD AND NECK
    DASMAHAPATRA, KS
    CITRIN, P
    HILL, GJ
    YEE, R
    MOHITTABATABAI, MA
    RUSH, BF
    JOURNAL OF CLINICAL ONCOLOGY, 1985, 3 (11) : 1486 - 1489
  • [3] CISPLATIN AND 5-FLUOROURACIL CHEMOTHERAPY IN ADVANCED OR RECURRENT SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK
    MERCIER, RJ
    NEAL, GD
    MATTOX, DE
    GATES, GA
    POMEROY, TC
    VONHOFF, DD
    CANCER, 1987, 60 (11) : 2609 - 2612
  • [4] TREATMENT OF SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK WITH CISPLATIN AND 5-FLUOROURACIL
    AMREIN, PC
    WIETZMAN, SA
    JOURNAL OF CLINICAL ONCOLOGY, 1985, 3 (12) : 1632 - 1639
  • [5] SEQUENTIAL METHOTREXATE AND 5-FLUOROURACIL WITH BLEOMYCIN AND CISPLATIN IN THE CHEMOTHERAPY OF ADVANCED SQUAMOUS CANCER OF THE HEAD AND NECK
    VOGL, SE
    KOMISAR, A
    KAPLAN, BH
    ENGSTROM, PF
    KASULE, OH
    STOLBACH, L
    LERNER, H
    MUGGIA, F
    CANCER, 1986, 57 (04) : 706 - 710
  • [6] MULTIMODALITY THERAPY OF LOCALLY ADVANCED SQUAMOUS-CELL CARCINOMA OF HEAD AND NECK (H AND N CA) - RESPONSE TO NEOADJUVANT CHEMOTHERAPY (CT) WITH CISPLATIN (DDP), 5-FLUOROURACIL (FU), BLEOMYCIN (B), MITOMYCIN-C (M) AND HYDROXYUREA (H)
    FOUNTZILAS, G
    SRIDHAR, KS
    APOSTOLIDIS, T
    DANIILIDIS, J
    ZARAMBOUKAS, T
    VRITSIOS, A
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1987, 28 : 225 - 225
  • [7] RANDOMIZED COMPARISON OF 5-FLUOROURACIL (5-FU) AND CISPLATINUM (DDP) VS NO CHEMOTHERAPY PRIOR TO RADIOTHERAPY AND SURGERY IN PATIENTS WITH LOCALLY ADVANCED HEAD AND NECK (H-AND-N) CANCER
    HAAS, C
    TOOHILL, R
    BYHARDT, R
    MALIN, T
    GROSSMAN, T
    RITCH, P
    COX, J
    LIBNOCH, J
    HAAS, J
    CANCER DRUG DELIVERY, 1986, 3 (01): : 59 - 59
  • [8] SEQUENTIAL TRIAL OF INITIAL CHEMOTHERAPY FOR ADVANCED CANCER OF THE HEAD AND NECK - DDP VERSUS DDP + 5-FLUOROURACIL
    CONINX, P
    NASCA, S
    LEBRUN, D
    PANIS, X
    LUCAS, P
    GARBE, E
    LEGROS, M
    CANCER, 1988, 62 (09) : 1888 - 1892
  • [9] MODIFIED 5-FLUOROURACIL (5FU)+ CISPLATINUM (CP) REGIMEN IN ADVANCED SQUAMOUS HEAD AND NECK-CANCER (HNC)
    KRASNOW, SH
    WADLEIGH, RG
    ANDERSON, AJ
    WHITE, KS
    COHEN, MH
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1987, 28 : 216 - 216
  • [10] CISPLATIN (DDP) PHARMACOKINETICS - CONTINUOUS INFUSION (CI) VS INTERMITTENT BOLUS (IB) IN THE TREATMENT OF HEAD AND NECK-CANCER (H-AND-N CA)
    BELLIVEAU, JF
    FORASTIERE, AA
    VOGEL, W
    GOREN, M
    POSNER, M
    OLEARY, G
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1987, 28 : 189 - 189
12345